Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1976 Dec;18:13–23. doi: 10.1289/ehp.761813

Developmental aspects of xenobiotic transformation.

W Klinger, D Muller
PMCID: PMC1475288  PMID: 20303

Abstract

In most laboratory animals monooxygenases are apparently absent or barely detectable in fetal organs until just before birth. In this contribution hepatic cytochrome P-450-dependent reactions in the rat are considered only. The results are interpreted on basis of the reaction scheme of Estabrook. To avoid methodological pitfalls the basic kinetics for all reactions investigated have been investigated with liver preparations from newborn and adult rats. The low monooxygenase activity of rat liver during the perinatal period can be observed even under optimal conditions for the in vitro enzyme assay. There are different developmental patterns for various reactions O-demethylation of codeine, phenazone-hydroxylation, first and second steps on N-demethylation of amidopyrine, N-demethylation of ethylmorphine. There are marked differences not only in Vmax but also in the postnatal development of Km and the inductibility by phenobarbital. Thus the existence of a different cytochrome P-450 is evident also by this approach. The low monooxygenase activity of rat liver during the perinatal period is not due to a lack of NADPH or NADH, to an age-dependent NADPH cytochrome P-450 reductase activity or to an age-dependent NADH-cytochrome P-450 reduction. Moreover this low activity is not due to an insufficient mitochondria-endoplasmic reticulum interaction. It is accompanied by low delta Amax after addition of a typical type I substrate (hexobarbital) and by a small amount of metyrapone-binding centers: it can be explained by a smaller percentage of active cytochrome P-450 in comparison to adult rat liver.

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cinti D. L., Ritchie A., Schenkman J. B. Hepatic organelle interaction. II. Effect of tricarboxylic acid cycle intermediates on N-demethylation and hydroxylation reactions in rat liver. Mol Pharmacol. 1972 May;8(3):339–344. [PubMed] [Google Scholar]
  2. Correia M. A., Mannering G. J. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. I. Effects of activation and inhibition of the fatty acyl coenzyme A desaturation system. Mol Pharmacol. 1973 Jul;9(4):455–469. [PubMed] [Google Scholar]
  3. Davies D. S., Gigon P. L., Gillette J. R. Sex differences in the kinetic constants for the N-demethylation of ethylmorphine by rat liver microsomes. Biochem Pharmacol. 1968 Sep;17(9):1865–1872. doi: 10.1016/0006-2952(68)90102-0. [DOI] [PubMed] [Google Scholar]
  4. Estabrook R. W., Matsubara T., Mason J. I., Werringloer J., Baron J. Studies on the molecular function of cytochrome P-450 during drug metabolism. Drug Metab Dispos. 1973 Jan-Feb;1(1):98–110. [PubMed] [Google Scholar]
  5. FOUTS J. R., ADAMSON R. H. Drug metabolism in the newborn rabbit. Science. 1959 Apr 3;129(3353):897–898. doi: 10.1126/science.129.3353.897. [DOI] [PubMed] [Google Scholar]
  6. Fouts J. R., Devereux T. R. Developmental aspects of hepatic and extrahepatic drug-metabolizing enzyme systems: microsomal enzymes and components in rabbit liver and lung during the first month of life. J Pharmacol Exp Ther. 1972 Nov;183(2):458–468. [PubMed] [Google Scholar]
  7. Furner R. L., Gram T. E., Stitzel R. E. The influence of age, sex and drug treatment on microsomal drug metabolism in four rat strains. Biochem Pharmacol. 1969 Jul;18(7):1635–1641. doi: 10.1016/0006-2952(69)90151-8. [DOI] [PubMed] [Google Scholar]
  8. Gram T. E., Guarino A. M., Schroeder D. H., Gillette J. R. Changes in certain kinetic properties of hepatic microsomal aniline hydroxylase and ethylmorphine demethylase associated with postnatal development and maturation in male rats. Biochem J. 1969 Jul;113(4):681–685. doi: 10.1042/bj1130681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moldeus P. W., Cha Y. N., Cinti D. L., Schenkman J. B. Hepatic organelle interaction. 3. Mitochondrial modification of microsomal drug metabolism. J Biol Chem. 1973 Dec 25;248(24):8574–8584. [PubMed] [Google Scholar]
  10. Müller D., Lübbe H., Klinger W. The NADPH-dependent cytochrome P-450 reduction in liver microsomes of rats of different ages with and without phenobarbital pretreatment. Acta Biol Med Ger. 1975;34(8):1333–1337. [PubMed] [Google Scholar]
  11. Roots I., Hildebrandt A. G. Determination of active centers of hepatic microsomal cytochrome P-450 by metyrapone, applying mutual depletion system kinetics. Drug Metab Dispos. 1973 Jan-Feb;1(1):194–198. [PubMed] [Google Scholar]
  12. Ullrich V. On the hydroxylation of cyclohexane in rat liver microsomes. Hoppe Seylers Z Physiol Chem. 1969 Mar;350(3):357–365. doi: 10.1515/bchm2.1969.350.1.357. [DOI] [PubMed] [Google Scholar]
  13. Wilson J. T. Alteration of normal development of drug metabolism by injection of growth hormone. Nature. 1970 Feb 28;225(5235):861–863. doi: 10.1038/225861a0. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES